Picture of Biomarin Pharmaceutical logo

BMRN Biomarin Pharmaceutical Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Annual balance sheet for Biomarin Pharmaceutical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments1,3961,0847541,0651,014
Net Total Accounts Receivable
Net Total Receivables261343377448373
Total Inventory
Total Other Current Assets
Total Current Assets2,2072,0561,9422,3422,274
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment8979491,0701,0901,082
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets4,6334,4274,6905,8486,003
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities817523933493540
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities1,8241,4591,5681,7421,733
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity2,8092,9683,1224,1064,271
Total Liabilities & Shareholders' Equity4,6334,4274,6905,8486,003
Total Common Shares Outstanding

Or unlock with your email

Or unlock with your email